OOIR: Observatory of International Research

Papers

(The H4-Index of Neoplasia is 28. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)

Article	Citations
Corrigendum to “Tumorigenicity of IL-1α- and IL-1β-Deficient Fibrosarcoma Cells” [Neoplasia, Volume 10, Issue 6, June 2008, Pages 549–562]	1744
DHX34 deficiency triggers tumor-intrinsic immunity via a dsRNA-mediated type I interferon pathway activation in HCC	117
Corrigendum to “Structure-function studies of the bHLH phosphorylation domain of TWIST1 in prostate cancer cells” [Neoplasia 17 (2014) 85]	100
ARID1A loss sensitizes colorectal cancer cells to floxuridine	62
Epitranscriptomic mechanisms of androgen signalling and prostate cancer	59
Therapeutic benefit of the dual ALK/FAK inhibitor ESK440 in ALK-driven neuroblastoma	59
5-Aza-2′-deoxycytidin (Decitabine) increases cancer-testis antigen expression in head and neck squamous cell carcinoma and modifies immune checkpoint expression, especially in CD39-positive CD8 and CD	57
Single cell analysis unveils the commonality and heterogeneity between nasopharyngeal and oropharyngeal carcinoma	56
Visualizing mast cell migration to tumor sites using sodium iodide symporter of nuclear medicine reporter gene	50
L-methionine promotes CD8+ T cells killing hepatocellular carcinoma by inhibiting NR1I2/PCSK9 signaling	46
Sialylated IgG-activated integrin β4-Src-Erk axis stabilizes c-Myc in a p300 lysine acetyltransferase-dependent manner to promote colorectal cancer liver metastasis	45
The GSK3 kinase and LZTR1 protein regulate the stability of Ras family proteins and the proliferation of pancreatic cancer cells	45
High metastatic tumor-derived CXCL16 mediates liver colonization metastasis by inducing Kupffer cell polarization via the PI3K/AKT/FOXO3a pathway	44
Combination of sunitinib and 177Lu-labeled antibody cG250 targeted radioimmunotherapy: A promising new therapeutic strategy for patients with advanced renal cell cancer	42
New horizons in B-cell lymphoma immunotherapy: From immune checkpoints to precision medicine	42
Combined radio-immunotherapy: An opportunity to increase the therapeutic ratio of oligometastasis-directed radiotherapy	42
Retraction notice to “Role of Autophagy as a Survival Mechanism for Hypoxic Cells in Tumors” [Neoplasia 18 (2016) 347- 355/201]	41
Mutational signatures and their association with survival and gene expression in urological carcinomas	41
RUNX2 enhances bladder cancer progression by promoting glutamine metabolism	40
Myxoid glioneuronal tumor: Histopathologic, neuroradiologic, and molecular features in a single center series	37
Time-restricted feeding affects the fecal microbiome metabolome and its diurnal oscillations in lung cancer mice	37
From adenoma to CRC stages: the oral-gut microbiome axis as a source of potential microbial and metabolic biomarkers of malignancy	35
Tumor-Infiltrating Immune Cells in Colorectal Cancer	34
Rezatapopt: A promising small-molecule “refolder” specific for TP53Y220C mutant tumors	32
A spatiotemporal atlas of orchiectomy-induced androgen deprivation-mediated modulation of cellular composition and gene expression in the mouse prostate	32

Regulatory mechanisms of the Hippo/YAP axis by G-protein coupled estrogen receptor in gastric signet-ring cell carcinoma	31
Leptomeningeal dissemination in pediatric brain tumors	30
Advanced progress of spatial metabolomics in head and neck cancer research	29
Metabolic and imaging phenotypes associated with RB1 and TP53 loss in prostate cancer	28